Cigna Options Tilt Bullish as Print Approaches

CI enters Thursday's Q3 earnings with options traders tilting more bullishly than at almost any point in the past year. Among its closest managed-care peers, the picture is broadly similar: ELV gained 2.7% on the week, UNH added 4.2%, and MD surged 7.0%. CI's own 2.4% weekly gain is solid but sits below the peer median, which is notable given that its put/call ratio has dropped to 0.42, the lowest in twelve months and more than 1.6 standard deviations below its 20-day average of 0.52. Calls are clearly dominating options flow into the print. Short interest is equally unexciting from a bear's perspective: at 2.4% of free float, with shares short falling 6.6% over the past week, there is little evidence of a building short thesis. Borrow conditions confirm this. Availability is effectively unlimited, and cost to borrow sits at 0.36%, a routine level for a large-cap name.

The analytic debate centres on whether Cigna's PBM transition is a managed restructuring or a margin trap. Bulls point to Evernorth's specialty pharmacy unit, which supports more than one million complex-condition patients and is expected to grow 8% to 12% annually through 2030. Management has guided for at least $45 in adjusted EPS by CY30. Piper Sandler reinforced that view earlier this month, raising its target to $370 while keeping an Overweight. RBC reiterated Outperform with a $337 target. Bears argue the move from a rebate-driven to a Signature fee structure has already forced Evernorth margin guidance down from 3.5-4.5% to 3.0-3.5% for CY26, with further risk from medical cost inflation and slower membership growth. Jefferies and Raymond James both cut ratings in early August following the previous print, and the stock fell roughly 5.9% that day and another 7.2% over the following five days, the sharpest reaction in recent quarters. The consensus has settled at Hold, with a mean target of $342, about 12% above the current $305.78.

Institutional ownership is stable and concentrated. BlackRock held 8.9% of shares as of September 30, adding roughly 840,000 shares in the most recent period. Dodge and Cox added 618,000 shares, and State Street added 399,000. The holder count of 413 institutions reflects steady, unconcentrated demand rather than speculative positioning. No activist 13D is on the register. The ORTEX short score of 34.3 has been drifting gently lower across October, consistent with the decline in shares short, and ranks in the 51st percentile for the sector. That is not a signal pointing strongly in either direction.

The print will test whether Cigna's confidence in $30.45 of adjusted EPS for CY26 holds after a quarter in which the Signature transition was further in motion, and whether Evernorth can maintain the volume growth story even as its margin corridor narrows.